#United States #Washington #Medicare #MedPAC #Amol Navathe

Dr. Amol Navathe: A New Era for MedPAC

On June 8, 2026, the U.S. Government Accountability Office (GAO) announced the appointment of Dr. Amol Navathe as the new Chair of the Medicare Payment Advisory Commission (MedPAC). Dr. Navathe, a highly regarded expert in both internal medicine and health care economics, is set to lead the commission through a crucial period until April 2029. His extensive background in health care financing and behavioral economics positions him perfectly to tackle the challenges faced by the Medicare program today.

A Leader at a Critical Time

MedPAC has served as a vital nonpartisan advisory body to Congress for nearly three decades, addressing a broad range of issues concerning the Medicare program. Acting Comptroller General of the United States, Orice W. Brown, expressed confidence in Dr. Navathe's leadership. He stated, "I am confident that the new leadership, in collaboration with commission members and staff, will continue to support congressional deliberations with robust, evidence-based information and recommendations." Dr. Navathe himself conveyed his commitment to enhancing the support given to Congress and Medicare beneficiaries: "I am honored to step into this role and lead MedPAC's work in support of the Medicare program and its beneficiaries."

A Comprehensive Background

Dr. Navathe's experience is vast and varied. He holds a professorship in Medical Ethics and Health Policy at the Perelman School of Medicine at the University of Pennsylvania, as well as a professorship in Healthcare Management and Economics at the Wharton School. His role as a Senior Fellow at the Leonard Davis Institute of Health Economics further underscores his dedication to bridging the gap between medical practice and economic policy.

A pioneer in using behavioral economics to develop both financial and nonfinancial incentives for improving patient outcomes, Dr. Navathe has devoted significant efforts to reducing prescription drug costs within the Medicare Part B program.

His approach emphasizes value-based care during a time when the Medicare program faces complex fiscal obstacles and a shifting landscape. Furthermore, Dr. Navathe's entrepreneurial background, including previous roles at SCAN Health Plan and Hawaii Medical Services Association, gives him an invaluable perspective on efficient Medicare Advantage plans.

A Legacy of Excellence

The Navathe family has a legacy of academic achievement and service. Dr. Amol Navathe’s father, Dr. Shamkant B. Navathe, is a distinguished computer scientist and professor at the Georgia Institute of Technology, known for his significant contributions to data systems and education. This family tradition underscores a commitment to mentorship and innovation, which is essential in fields as diverse as computer science, medicine, and healthcare policy.

Looking Forward

Dr. Navathe's distinct role as a clinician and health economist will guide MedPAC in its ongoing advisement to Congress on crucial payment accuracy issues, the implications of these payments on healthcare plans and providers, and ensuring access to high-quality care for millions of Medicare beneficiaries. With his leadership, MedPAC is poised to navigate the intricacies of healthcare economics effectively while upholding its commitment to transparency and research-driven policymaking.

As Medicare faces considerable challenges, the appointment of Dr. Amol Navathe marks a significant step towards fostering innovative solutions that prioritize patient care while managing costs. His dual expertise may be exactly what is needed to guide Medicare towards a sustainable and efficient future.